BAYRYCAUTIOUS

BAYRY Return on Equity (ROE) Analysis

-6.9%

Higher than 27% of Healthcare sector peers

Updated 875h ago·SEC filings & market data

Key Takeaway

BAYRY's Return on Equity (ROE) of -6.9% means the company is losing money relative to the equity shareholders have invested — for every $100 of equity, it generated a $6.90 loss.

Sector Performance

27th percentile

BAYRY

-6.9%

Sector Median

10.1%

Sector Avg

68.8%

Prior Period

-13.4%(May 2026)

↑ Improving

📊

Deep Analysis

BAYRY's Return on Equity (ROE) of -6.9% means the company is losing money relative to the equity shareholders have invested — for every $100 of equity, it generated a $6.90 loss.

This sits well below the healthcare sector median of 8.9%, placing BAYRY in the 31st percentile among its peers. The year-over-year change is not available, but the quarter-over-quarter change shows improvement of +48.5%, moving from -13.4% to the current -6.9%. The combination of a deeply negative ROE with a recent upward trend suggests the company is still destroying shareholder value, though the pace of losses is narrowing — presenting both ongoing risk and a potential turnaround case if the improvement continues. This metric directly supports the overall CAUTIOUS verdict; a negative ROE far below the sector median indicates weak profitability and high investment risk.

Frequently Asked Questions

What does the Return on Equity (ROE) tell investors about BAYRY?

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.

How is the Return on Equity (ROE) calculated?

Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.

How does BAYRY's Return on Equity (ROE) compare to its sector?

BAYRY's Return on Equity (ROE) of -6.9% compares to a Healthcare sector median of 10.1%, placing it in the 27th percentile.

Who are BAYRY's closest peers by Return on Equity (ROE)?

The closest Healthcare peers by Return on Equity (ROE) include: ALGN (10.1%), TECH (9.0%), BIIB (7.7%), ABT (12.5%), TMO (13.5%).

📚

Learn More About Return on Equity (ROE)

What Is Return on Equity (ROE) and Is Higher Always Better?

Return on equity ROE measures how efficiently a company generates profit from shareholder capital. Learn how to decompose ROE using DuPont analysis and why high leverage can make it dangerous—with Apple and JPMorgan examples.

The Formula

Net Income / Shareholders' Equity

Why It Matters

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.